Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Fraser

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
The New Zealand Medical Journal|July 13, 2011
Nasal carriage of Staphylococcus aureus in healthy AucklandersNicola Best, John D Fraser, Paul B Rainey, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2012
A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitorsKatrin Schünemann, Stephen Connelly, Renata Kowalczyk, et al.
Emerging Infectious Diseases|June 25, 2014
Staphylococcus aureus infections in New Zealand, 2000-2011Deborah A Williamson, Jane Zhang, Stephen R Ritchie, et al.
Immunology and Cell Biology|April 4, 2024
Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureusJanlin Ying Hui Chan, Fiona Clow, Victoria Pearson, et al.
American Journal of Rhinology & Allergy|July 18, 2012
Intramucosal bacterial microcolonies exist in chronic rhinosinusitis without inducing a local immune responseAndrew J Wood, John D Fraser, Simon Swift, et al.
Infection and Immunity|September 6, 2012
Structural and functional properties of staphylococcal superantigen-like protein 4Stefan J Hermans, Heather M Baker, Richard P Sequeira, et al.
Organic & Biomolecular Chemistry|December 19, 2013
Synthesis of the 2-methylene analogue of the HRV 3C protease inhibitor thysanone (2-carbathysanone)Katrin Schünemann, Daniel P Furkert, Eun Cho Choi, et al.
Plos One|April 3, 2014
An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cellsJulie D McIntosh, Kristy Manning, Shilpa Chokshi, et al.
Critical Care Medicine|April 2, 2008
Increased surface toll-like receptor 2 expression in superantigen shockPhilip A Hopkins, Alison C Pridmore, Stephan Ellmerich, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2007
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1Paul A Ramsland, Natasha Willoughby, Halina M Trist, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
The New Zealand Medical Journal|July 13, 2011
Nasal carriage of Staphylococcus aureus in healthy AucklandersNicola Best, John D Fraser, Paul B Rainey, et al.
Bioorganic & Medicinal Chemistry Letters|July 6, 2012
A simple solid phase, peptide-based fluorescent assay for the efficient and universal screening of HRV 3C protease inhibitorsKatrin Schünemann, Stephen Connelly, Renata Kowalczyk, et al.
Emerging Infectious Diseases|June 25, 2014
Staphylococcus aureus infections in New Zealand, 2000-2011Deborah A Williamson, Jane Zhang, Stephen R Ritchie, et al.
Immunology and Cell Biology|April 4, 2024
Feasibility of using a combination of staphylococcal superantigen-like proteins 3, 7 and 11 in a fusion vaccine for Staphylococcus aureusJanlin Ying Hui Chan, Fiona Clow, Victoria Pearson, et al.
American Journal of Rhinology & Allergy|July 18, 2012
Intramucosal bacterial microcolonies exist in chronic rhinosinusitis without inducing a local immune responseAndrew J Wood, John D Fraser, Simon Swift, et al.
Infection and Immunity|September 6, 2012
Structural and functional properties of staphylococcal superantigen-like protein 4Stefan J Hermans, Heather M Baker, Richard P Sequeira, et al.
Organic & Biomolecular Chemistry|December 19, 2013
Synthesis of the 2-methylene analogue of the HRV 3C protease inhibitor thysanone (2-carbathysanone)Katrin Schünemann, Daniel P Furkert, Eun Cho Choi, et al.
Plos One|April 3, 2014
An engineered non-toxic superantigen increases cross presentation of hepatitis B virus nucleocapsids by human dendritic cellsJulie D McIntosh, Kristy Manning, Shilpa Chokshi, et al.
Critical Care Medicine|April 2, 2008
Increased surface toll-like receptor 2 expression in superantigen shockPhilip A Hopkins, Alison C Pridmore, Stephan Ellmerich, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 2007
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1Paul A Ramsland, Natasha Willoughby, Halina M Trist, et al.
Pageof 8